LIKERT五分量表法在建立儿科人血白蛋白临床应用评价标准的应用

Establishment and Application of Clinical Evaluation Criteria for Pediatric Human Serum Albumin Based on Likert Five Subscale Method

目的:建立儿科人血白蛋白临床应用评价标准,并依据标准分析评价儿科人血白蛋白的临床应用现状。方法:通过LIKERT五分量表法确定儿科人血白蛋白合理应用评价指标;根据评价指标,建立人血白蛋白临床应用评价标准;根据建立的评价标准对杭州市儿童医院2019年6月至2020年5月使用人血白蛋白的127例非手术住院病例进行临床应用现状分析与评价。结果:根据人血白蛋白评价标准的主要指标点评127份医嘱,主要存在与其他药物连续静脉滴注时未冲管21例(38.18%)、剂量或给药途径不合理18例(32.73%)、治疗低蛋白血症者未达到使用指征8例(14.55%)、无适应证或适应证不适宜6例(10.91%)、滴速与溶媒不合理2例(3.64%)。结论:通过LIKERT五分量表法建立儿科人血白蛋白临床应用评价标准,评价并分析人血白蛋白临床应用的不合理因素,对促进临床合理使用人血白蛋白具有一定价值。

Objective:To establish the evaluation criteria for the clinical application of human serum albumin in pediatrics,and analyze and evaluate the clinical application status of human serum albumin according to the criteria.Methods:Firstly,the evaluation index of pediatric human serum albumin rational application was determined by Likert five subscale method.Secondly,according to the evaluation index,the clinical application evaluation standard of human serum albumin was established.Finally,according to the established evaluation criteria,the clinical application status of 127 non-surgical inpatients who used human serum albumin from June 2019 to May 2020 was analyzed and evaluated.Results:According to the main indicators of human serum albumin evaluation criteria,127 medical orders were evaluated.There were 21 cases(38.18%)of not flushing tube when continuous intravenous drip with other drugs,18 cases(32.73%)of unreasonable dosage or administration route,8 cases(14.55%)who did not meet the indications for the treatment of hypoproteinemia,6 cases(10.91%)with no indication or inappropriate indication,and 2 cases(3.64%)of unreasonable dripping speed or solvent.Conclusion:The evaluation standard of clinical application of human serum albumin in pediatrics is established by Likert five subscale method,and the unreasonable factors of clinical application of human serum albumin are evaluated and analyzed,to promote the rational use of human serum albumin in the clinic.